Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Saginaw, MI - Saturday, April 17, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 04/17/2021 at 8:30 AM (EDT)

    The ASAM Treatment of Opioid Use Disorder Course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices.

    image

    Host: Central Michigan University

    Saturday, April 17, 2021 | 8:30 am - 4:30 pm ET

    Live Virtual Course

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD – Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board
    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures 
    Mount Sinai Beth Israel, New York, NY

    Marian Currens, CRNP – Does Disclose 
    University of Maryland Baltimore, Baltimore, MD

    • ASAM, Consultant/Advisory Board, Clinical Condition: MedNP ED

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures 
    First Judicial District Court, Santa Fe, NM

    Daniel P. Alford, MD, MPH, DFASAM - No Relevant Financial Disclosures 
    Boston Medical School and Boston University School, Boston, MA

    Corey Waller, MD, MS, DFASAM, FACEP – No Relevant Financial Disclosures 
    Health Management Associates, Lansing, MI


    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to infobuprenorphine@samhsa.hhs.gov. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    The ASAM Treatment of Opioid Use Disorder Course has been made available in part by an unrestricted educational grant from Indivior, Inc.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • ASAM Criteria Course: Friday, April 16, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 04/16/2021 at 10:30 AM (EDT)

    The ASAM Criteria Course is a practical workshop designed to help counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

    image

            image


    Friday, April 16, 2021 
    8:30 am - 5:30 pm MT

    Overview

    The ASAM Criteria Course will comprise of a comprehensive suite of competency-based learning activities in a live interactive webinar delivery format that meets the learning needs of the multiple audiences making use of the Criteria and results in the appropriate use of the Criteria in practice. This is a practical training designed to help beginner, intermediate, and advanced counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities. Learners will have the opportunity to aske the presenter questions in real time, participate in polling questions and break into small groups. 

    The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training on The ASAM Criteria can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

    Learning Objectives

    1. Describe the underlying principles and concepts of the ASAM Criteria.
    2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment.
    3. Determine treatment priorities based on risk assessment to guide treatment and service planning.
    4. Determine an appropriate level of care and treatment priorities based on risk assessment.
    5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

    Registration Deadline: There is no registration deadline. Learners may not register for the course after it has begun. 


    ACGME Competencies

    • Patient Care and Procedural Skills
    • Medical Knowledge
    • Practice-Based Learning and Improvement
    • Systems Based Practice

    Target Audience

    • Counselors
    • Social Workers
    • Administrators
    • Other Clinical Staff

    Christine R. Mulford

    RN, MSN, FNP-BC

    Christine brings her more than 15 years of clinical and leadership experience as a Nurse Practitioner to the practice of addiction medicine. She is passionate about individualized patient care as well as community education to end the stigma of substance use and mental health issues.

    Together with her physician partner, she started the first Emergency Room based withdrawal management service in the greater Phoenix area. Additionally, she maintains a private addiction medicine practice in Scottsdale, Arizona. Christine received her Master’s Degree in Nursing from Vanderbilt University where she was the 1998 Julia Hereford Merit Scholar. She resides in Phoenix, Arizona with her 2 sometimes well-behaved dogs. She enjoys live music, sports, and trying new hot sauces.

    Jennifer Harrison,

    PhD, LMSW, CAADC

    Jennifer r is a social worker, chemical addictions counselor, and an associate professor and the interim director for the School of Social Work at Western Michigan University.  Jennifer’s clinical work focuses on integrated substance use, mental health, and physical health services for individuals with co-occurring needs.  Her research interests and publication record include international social justice, co-occurring mental health, substance abuse, and medical needs among adults, implementation of evidence-based practices, and peer services in behavioral health.  

    Jennifer co-authored the book Tips and topics:  Opening the toolbox for transforming services and systems with David Mee-Lee.  She has presented on interprofessional research and teaching in the U.S and internationally, and served on multiple expert panels with SAMHSA.  Jennifer is a co-principal investigator in two HRSA funded projects to impact the interprofessional behavioral health workforce.  She has co-developed a digital application, Goal Scaling Solutions, for use in telehealth and education settings, to help people develop, monitor, and communicate about their goals for wellness and recovery.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Academy of Family Physicians (AAFP)

    The AAFP has reviewed The ASAM Criteria Course, and deemed it acceptable for 8.00 In-Person, Live (could include online) AAFP Prescribed Credit(s). Term of approval is from 01/29/2021 to 01/29/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    AMA/AAFP Equivalency

    AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

    ASWB Accreditation Statement

    The ASAM Criteria Course, Course #3225, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by The American Society of Addiction Medicine as an individual course. Individual courses, not providers, are approved at the course level. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ACE course approval period: 10/01/2020 - 10/01/2022. Social workers completing this course receive 8 Clinical continuing education credits.

    National Board for Certified Counselors ACEP

    The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Catherine Friedman, MD, FAPA, DFASAM – No Relevant Financial Disclosures 

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Christine R. Mulford, RN, MSN, FNP-BC – No Relevant Financial Disclosures 
    Phoenix ER and Medical Hospital/SHMDPC, Phoenix, AZ

    Jennifer Harrison, PhD, LMSW, CAADC – No Relevant Financial Disclosures 
    School of Social Work, Western Michigan University, Hopkins, MI


    Planning Committee Disclosure Information

    Corey Waller, MD, MS, DFASAM, FACEP, Chair (Chair) – No Relevant Financial Disclosures 

    David Mee-Lee, MD, FASAM – No Relevant Financial Disclosures 

    David R. Gastfriend, MD, DFASAM – No Relevant Financial Disclosures 

    Lewis Breitner, PhD, LADC, LMFT – No Relevant Financial Disclosures 

    Amy Davis, DO, MS, FACP, FAAHPM – No Relevant Financial Disclosures 

    Jennifer Harrison, PhD, LMSW, CAADC – No Relevant Financial Disclosures 

    Melissa Holland, MA, MD, FACOG, CAADC – No Relevant Financial Disclosures 

    Christine Mulford, RN, MSN, FNP-BC – No Relevant Financial Disclosures 

    Surita Rao, MBBS, FASAM – Does Disclose

    • John Snow, Inc., Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    J. Paul Seale, MD, FASAM – No Relevant Financial Disclosures 

    Gerald D. Shulman, MA, MAC, FACATA – No Relevant Financial Disclosures 

    How to Claim Credits


    To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

    STEP 1

    Complete the course.

    STEP 2

    Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

    STEP 3

    Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

    Fees


    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Resident, Student, Associate Members: $99.00

    All refund requests and cancellations must be made in writing and emailed to ASAM's Education Department: education@asam.org

    If you require ADA Accommodations, please contact ASAM's Education Department.

    All questions and concerns must be made in writing and emailed to ASAM's Education Department: education@asam.org

    System Requirements


    Please ensure that the location of where you plan to access the live stream program meets hardware, software and bandwidth requirements well in advance. 

    It is recommended that you use a PC or MAC with an updated Internet Browser. Internet Explorer is NOT recommended
    • Ensure that pop-ups blockers are disabled in your Internet browser settings.
    • Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers so you can hear the presenters.

    Browser Tests: Please take the following browser test. Please review the following Technical Requirements and be sure your system and networks are up-to-date. 

    https://support.zoom.us/hc/en-us/articles/115002262083-Joining-a-test-meeting

    Minimum System Requirements: 2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended)

    Minimum Browser Requirements: Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/ 

    • Windows 7 or later 
    • Mac OS X 10.9 or later 
    • Chrome 60 or greater 
    • Firefox 52 or greater 
    • Edge 14 or greater 
    • Safari 10 or greater 
    • iOS 10 or greater 

    Internet Explorer is NOT recommended 

    IP Addresses and Ports to Allow for HTML5: 

    • 72.32.161.112 port 80, 443 (web and audio) 
    • 72.32.200.104 port 80, 443 (web and audio) 
    • 72.32.221.65 ports 80, 443 (web and audio)
    • 72.32.221.66 ports 80, 443 (web and audio)
    • 67.203.7.114 ports 80, 443 (web and audio)
    • Register
      • Non-Member - $199
      • Regular Member - $149
      • Retired - $149
      • Early Career Physician - $149
      • Resident - $99
      • Student - $99
      • Associate - $99
      • ASAM Staff - Free!
      • International Member - $149
      • Emeritus Member - $149
      • Provisional Member - $149
      • Fellow Member - $149
      • Honorary Member - $149
      • CRT Member - $149
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - MOC - Thursday, April 8, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 04/08/2021 at 8:00 AM (EDT)

    The ASAM Treatment of Opioid Use Disorder Course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices.

    image

    Host: Michigan Opioid Collaborative (MOC)

    Thursday, April 8, 2021 | 8:00 am - 5:00 pm ET

    Location: Ann Arbor, MI

    Live Virtual Course 

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Sheba Sethi

    MD

    Sheba Sethi, MD works as an addiction medicine consultant and primary care doctor at Packard Health. She is board certified in Internal Medicine and is a member of American Society of Addiction Medicine (ASAM). She graduated from Drexel University College of Medicine in 2016. She did her internal medicine residency training at Montefiore Medical Center Primary Care and Social Medicine program in the Bronx, NY. She is passionate about social medicine or the study of how social, economic, environmental and epidemiologic conditions impact health and disease. Her clinical interests involve treatment of substance use disorders as well as care of vulnerable populations.

    Christopher Frank

    MD, PhD

    Dr. Frank earned his undergraduate degree at the University of Michigan and graduated from Johns Hopkins University School of Medicine with an M.D. and a Ph.D. in molecular biology. He completed his family medicine residency at the University of Wisconsin in a specialized program designed to prepare family physicians to work in rural communities. Prior to joining the University of Michigan Department of Family Medicine, he worked eight years as a full-scope family physician in a Health Professional Shortage Area in Washington State, and as the health officer/medical director of a local health department. He taught medical students and residents as a clinical assistant professor in the University of Washington Department of Family Medicine. He also chaired a broad coalition that developed a regional response to the opioid crisis, served on the Washington State Board of Health, and led an innovative program that required mandatory reporting of fatal and non-fatal overdoses so patients could be quickly enrolled in evidence-based treatment and prevention services. His clinical interests include comprehensive primary care, including obstetrics, prevention and treatment of opioid-use disorders, and medical education. He is a waivered buprenorphine prescriber and treats patients with a range of substance-use disorders, including women struggling with opioid-use disorders during pregnancy. In addition to working with individual patients, he has been a supervising physician within a nurse-managed MAT program, and has worked on system-changes to improve access to treatment for patients in acute care settings and the criminal justice system.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD - Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board 

    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures 
    Mount Sinai Beth Israel, New York, NY

    Marian Currens, CRNP – Does Disclose 
    University of Maryland Baltimore, Baltimore, MD

    • ASAM, Consultant/Advisory Board, Clinical Condition: MedNP ED

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures 
    First Judicial District Court, Santa Fe, NM

    Daniel P. Alford, MD, MPH, DFASAM - No Relevant Financial Disclosures 
    Boston Medical School and Boston University School, Boston, MA

    Corey Waller, MD, MS, DFASAM, FACEP – No Relevant Financial Disclosures 
    Health Management Associates, Lansing, MI


    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs may upload copies of their training certificates on the Waiver Notification Form. NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - MOC - Monday, March 29, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 03/29/2021 at 8:00 AM (EDT)

    The ASAM Treatment of Opioid Use Disorder Course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices.

    image

    Host: Michigan Opioid Collaborative

    Monday, March 29, 2021 | 8:00 am - 5:00 pm ET

    Location: Ann Arbor, MI

    Live Virtual Course

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Cara Poland, MD, MEd, DFASAM

    MD, MEd, DFASAM

    Cara Poland, MD, MEd, DFASAM was trained in internal medicine at St. Joseph Mercy Hospital in Ann Arbor, Michigan and in addiction medicine at Boston Medical Center in Boston, Massachusetts. She has an interest in education physicians and physicians-in-training to improve care for patients with substance abuse and alcohol disorders. She is interested in medical student curriculum development and assessment, student well-being and identifying ways to improve the process of medical training. She sits on the Board of Directors for the Red Project and multiple leadership boards of various professional societies such as the Midwest Society of General Internal Medicine and American Society of Addiction Medicine. She is currently a physician at Spectrum Health's Center for Integrative Medicine.

    Christopher Frank

    MD, PhD

    Dr. Frank earned his undergraduate degree at the University of Michigan and graduated from Johns Hopkins University School of Medicine with an M.D. and a Ph.D. in molecular biology. He completed his family medicine residency at the University of Wisconsin in a specialized program designed to prepare family physicians to work in rural communities. Prior to joining the University of Michigan Department of Family Medicine, he worked eight years as a full-scope family physician in a Health Professional Shortage Area in Washington State, and as the health officer/medical director of a local health department. He taught medical students and residents as a clinical assistant professor in the University of Washington Department of Family Medicine. He also chaired a broad coalition that developed a regional response to the opioid crisis, served on the Washington State Board of Health, and led an innovative program that required mandatory reporting of fatal and non-fatal overdoses so patients could be quickly enrolled in evidence-based treatment and prevention services. His clinical interests include comprehensive primary care, including obstetrics, prevention and treatment of opioid-use disorders, and medical education. He is a waivered buprenorphine prescriber and treats patients with a range of substance-use disorders, including women struggling with opioid-use disorders during pregnancy. In addition to working with individual patients, he has been a supervising physician within a nurse-managed MAT program, and has worked on system-changes to improve access to treatment for patients in acute care settings and the criminal justice system.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD - Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board 

    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information



    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    • Fill out the Waiver Notification Form on SAMHSA’s website. You can upload a copy of your training certificate(s) directly to the Waiver Notification Form.

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • ASAM Criteria Course: Friday, March 19, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 03/19/2021 at 9:30 AM (EDT)

    The ASAM Criteria Course is a practical workshop designed to help counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

    image

            image


    Friday, March 19, 2021 
    8:30 am - 5:30 pm CT

    Overview

    The ASAM Criteria Course will comprise of a comprehensive suite of competency-based learning activities in a live interactive webinar delivery format that meets the learning needs of the multiple audiences making use of the Criteria and results in the appropriate use of the Criteria in practice. This is a practical training designed to help beginner, intermediate, and advanced counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities. Learners will have the opportunity to aske the presenter questions in real time, participate in polling questions and break into small groups. 

    The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training on The ASAM Criteria can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

    Learning Objectives

    1. Describe the underlying principles and concepts of the ASAM Criteria.
    2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment.
    3. Determine treatment priorities based on risk assessment to guide treatment and service planning.
    4. Determine an appropriate level of care and treatment priorities based on risk assessment.
    5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

    Registration Deadline: There is no registration deadline. Learners may not register for the course after it has begun. 


    ACGME Competencies

    • Patient Care and Procedural Skills
    • Medical Knowledge
    • Practice-Based Learning and Improvement
    • Systems Based Practice

    Target Audience

    • Counselors
    • Social Workers
    • Administrators
    • Other Clinical Staff

    Christine R. Mulford

    RN, MSN, FNP-BC

    Christine brings her more than 15 years of clinical and leadership experience as a Nurse Practitioner to the practice of addiction medicine. She is passionate about individualized patient care as well as community education to end the stigma of substance use and mental health issues.

    Together with her physician partner, she started the first Emergency Room based withdrawal management service in the greater Phoenix area. Additionally, she maintains a private addiction medicine practice in Scottsdale, Arizona. Christine received her Master’s Degree in Nursing from Vanderbilt University where she was the 1998 Julia Hereford Merit Scholar. She resides in Phoenix, Arizona with her 2 sometimes well-behaved dogs. She enjoys live music, sports, and trying new hot sauces.

    Jennifer Harrison,

    PhD, LMSW, CAADC

    Jennifer r is a social worker, chemical addictions counselor, and an associate professor and the interim director for the School of Social Work at Western Michigan University.  Jennifer’s clinical work focuses on integrated substance use, mental health, and physical health services for individuals with co-occurring needs.  Her research interests and publication record include international social justice, co-occurring mental health, substance abuse, and medical needs among adults, implementation of evidence-based practices, and peer services in behavioral health.  

    Jennifer co-authored the book Tips and topics:  Opening the toolbox for transforming services and systems with David Mee-Lee.  She has presented on interprofessional research and teaching in the U.S and internationally, and served on multiple expert panels with SAMHSA.  Jennifer is a co-principal investigator in two HRSA funded projects to impact the interprofessional behavioral health workforce.  She has co-developed a digital application, Goal Scaling Solutions, for use in telehealth and education settings, to help people develop, monitor, and communicate about their goals for wellness and recovery.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Academy of Family Physicians (AAFP)

    The AAFP has reviewed The ASAM Criteria Course, and deemed it acceptable for 8.00 In-Person, Live (could include online) AAFP Prescribed Credit(s). Term of approval is from 01/29/2021 to 01/29/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    AMA/AAFP Equivalency

    AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

    ASWB Accreditation Statement

    The ASAM Criteria Course, Course #3225, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by The American Society of Addiction Medicine as an individual course. Individual courses, not providers, are approved at the course level. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ACE course approval period: 10/01/2020 - 10/01/2022. Social workers completing this course receive 8 Clinical continuing education credits.

    National Board for Certified Counselors ACEP

    The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Catherine Friedman, MD, FAPA, DFASAM – No Relevant Financial Disclosures 

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Christine R. Mulford, RN, MSN, FNP-BC – No Relevant Financial Disclosures 
    Phoenix ER and Medical Hospital/SHMDPC, Phoenix, AZ

    Jennifer Harrison, PhD, LMSW, CAADC – No Relevant Financial Disclosures 
    School of Social Work, Western Michigan University, Hopkins, MI


    Planning Committee Disclosure Information

    Corey Waller, MD, MS, DFASAM, FACEP, Chair (Chair) – No Relevant Financial Disclosures 

    David Mee-Lee, MD, FASAM – No Relevant Financial Disclosures 

    David R. Gastfriend, MD, DFASAM – No Relevant Financial Disclosures 

    Lewis Breitner, PhD, LADC, LMFT – No Relevant Financial Disclosures 

    Amy Davis, DO, MS, FACP, FAAHPM – No Relevant Financial Disclosures 

    Jennifer Harrison, PhD, LMSW, CAADC – No Relevant Financial Disclosures 

    Melissa Holland, MA, MD, FACOG, CAADC – No Relevant Financial Disclosures 

    Christine Mulford, RN, MSN, FNP-BC – No Relevant Financial Disclosures 

    Surita Rao, MBBS, FASAM – Does Disclose

    • John Snow, Inc., Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    J. Paul Seale, MD, FASAM – No Relevant Financial Disclosures 

    Gerald D. Shulman, MA, MAC, FACATA – No Relevant Financial Disclosures 

    How to Claim Credits


    To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

    STEP 1

    Complete the course.

    STEP 2

    Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

    STEP 3

    Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

    Fees


    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Resident, Student, Associate Members: $99.00

    All refund requests and cancellations must be made in writing and emailed to ASAM's Education Department: education@asam.org

    If you require ADA Accommodations, please contact ASAM's Education Department.

    All questions and concerns must be made in writing and emailed to ASAM's Education Department: education@asam.org

    System Requirements


    Please ensure that the location of where you plan to access the live stream program meets hardware, software and bandwidth requirements well in advance. 

    It is recommended that you use a PC or MAC with an updated Internet Browser. Internet Explorer is NOT recommended
    • Ensure that pop-ups blockers are disabled in your Internet browser settings.
    • Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers so you can hear the presenters.

    Browser Tests: Please take the following browser test. Please review the following Technical Requirements and be sure your system and networks are up-to-date. 

    https://support.zoom.us/hc/en-us/articles/115002262083-Joining-a-test-meeting

    Minimum System Requirements: 2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended)

    Minimum Browser Requirements: Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/ 

    • Windows 7 or later 
    • Mac OS X 10.9 or later 
    • Chrome 60 or greater 
    • Firefox 52 or greater 
    • Edge 14 or greater 
    • Safari 10 or greater 
    • iOS 10 or greater 

    Internet Explorer is NOT recommended 

    IP Addresses and Ports to Allow for HTML5: 

    • 72.32.161.112 port 80, 443 (web and audio) 
    • 72.32.200.104 port 80, 443 (web and audio) 
    • 72.32.221.65 ports 80, 443 (web and audio)
    • 72.32.221.66 ports 80, 443 (web and audio)
    • 67.203.7.114 ports 80, 443 (web and audio)
    • Register
      • Non-Member - $199
      • Regular Member - $149
      • Retired - $149
      • Early Career Physician - $149
      • Resident - $99
      • Student - $99
      • Associate - $99
      • ASAM Staff - Free!
      • International Member - $149
      • Emeritus Member - $149
      • Provisional Member - $149
      • Fellow Member - $149
      • Honorary Member - $149
      • CRT Member - $149
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Phoenix, AZ - Friday, February 19, 2021

    Product not yet rated Contains 7 Component(s), Includes Credits Includes a Live Web Event on 02/19/2021 at 4:00 PM (EST)

    The ASAM Treatment of Opioid Use Disorder Course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: University of Arizona College of Medicine Phoenix

    Date: Friday, February 19, 2021 | 2pm – 6pm (MST)

     Live Virtual Course

    Online Portion Due: Thursday, February 18, 2021


    This course is offered in partnership with the American College of Obstetricians and Gynecologists (ACOG). The curriculum for this course has been specifically designed for women's health providers.

    Overview

    Welcome to The ASAM Treatment of Opioid Use Disorder Course online access. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live in person or via live webinar learning. The live in person or via live webinar portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live in person or via live webinar portion. You must complete both portions to receive credit for the course. 

    Getting Started

    To begin the online portion of the course, please log-in to your left and locate the box that says "View Course." If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password.  If you have any questions, please contact education@ASAM.org.

    Learning Objectives

    1. Identify the importance of screening for substance use disorders
    2. Describe the mechanism of opioid withdrawal
    3. Discuss options to treat opioid withdrawal
    4. Explain the safety and efficacy of buprenorphine to treat opioid use disorder
    5. Explain the safety of medications in antepartum, postpartum, and breastfeeding period
    6. Describe how to start a patient (induction) on buprenorphine in an office-based setting
    7. Discuss successful non-pharmacological ways to treat Neonatal Abstinence Syndrome

    Overall Objective

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Maria Manriquez

    MD, FACOG

    Maria Manriquez, M.D., FACOG is a University of Arizona College of Medicine Alumnus and currently directs the Pipeline Admissions and UMG Pain and Addition Curriculum at the University of Arizona College of Medicine Phoenix.  Dr. Manriquez brings vast experience in program direction that spans undergraduate education, medical education, graduate and continued medical education. Her service includes vice chair then chair of the Arizona section of American College of Obstetricians and Gynecologist (ACOG). She has served as At-Large Fellow for District VIII on the advisory council for ACOG. Dr. Manriquez currently sits on the Council of Resident Education and Gynecology (CREOG) and is the CREOG program chair. Dr Manriquez is one of two ACOG representatives to the AAMC CFAS.

    Dr. Manriquez was the principle investigator for a large CMS grant, awarded to Maricopa Integrated Health Systems (MIHS), aimed at investigating innovations in prenatal care models addressing preterm delivery rate, substance use disorders in pregnancy and care coordination. During Dr. Manriquez’s tenure at MIHS she was Associate Director of the Residency Program in OBGYN and was Vice Chair of the OBGYN department. Dr. Manriquez continues to maintain a clinical practice at MIHS focusing on substance use- disorders in pregnancy. She developed and directs the Pathway Scholars Program, a program addressing diversity in the physician workforce. The program prepares underprivileged students for medical school through a yearlong curriculum designed to position them to thrive once they matriculate. 

    Dr. Manriquez continues clinical practice focusing on substance use-disorders in pregnancy and parenting women. Her research and advocacy focus are aimed at investigating innovations in prenatal care models addressing preterm delivery rate, substance use disorders in pregnancy and care coordination.  

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD – Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board
    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Maria Manriquez, M.D., FACOG – No Relevant Financial Disclosures 

    University of Arizona College of Medicine, Phoenix, Arizona

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures 

    Mount Sinai Beth Israel, New York, NY 

    Marian Currens, CRNP – Does Disclose 
    University of Maryland Baltimore, Baltimore, MD

    • ASAM, Consultant/Advisory Board, Clinical Condition: MedNP ED

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures 
    First Judicial District Court, Santa Fe, NM

    Daniel P. Alford, MD, MPH, DFASAM - No Relevant Financial Disclosures 
    Boston Medical School and Boston University School, Boston, MA

    Corey Waller, MD, MS, DFASAM, FACEP – No Relevant Financial Disclosures 
    Health Management Associates, Lansing, MI


    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs may upload copies of their training certificates on the Waiver Notification Form. NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - $25
      • Regular Member - $25
      • Retired - $25
      • Early Career Physician - $25
      • Resident - $25
      • Student - $25
      • Associate - $25
      • ASAM Staff - Free!
      • International Member - $25
      • Emeritus Member - $25
      • Provisional Member - $25
      • Fellow Member - $25
      • Honorary Member - $25
      • CRT Member - $25
    • More Information
  • ASAM Criteria Course: Friday, February 19, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 02/19/2021 at 8:30 AM (EST)

    The ASAM Criteria Course is a practical workshop designed to help counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

    image

            image


    Friday, February 19, 2021 
    8:30 am - 5:30 pm ET

    Overview

    The ASAM Criteria Course will comprise of a comprehensive suite of competency-based learning activities in a live interactive webinar delivery format that meets the learning needs of the multiple audiences making use of the Criteria and results in the appropriate use of the Criteria in practice. This is a practical training designed to help beginner, intermediate, and advanced counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities. Learners will have the opportunity to aske the presenter questions in real time, participate in polling questions and break into small groups. 

    The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training on The ASAM Criteria can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

    Learning Objectives

    1. Describe the underlying principles and concepts of the ASAM Criteria.
    2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment.
    3. Determine treatment priorities based on risk assessment to guide treatment and service planning.
    4. Determine an appropriate level of care and treatment priorities based on risk assessment.
    5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

    Registration Deadline: There is no registration deadline. Learners may not register for the course after it has begun. 


    ACGME Competencies

    • Patient Care and Procedural Skills
    • Medical Knowledge
    • Practice-Based Learning and Improvement
    • Systems Based Practice

    Target Audience

    • Counselors
    • Social Workers
    • Administrators
    • Other Clinical Staff

    Christine R. Mulford

    RN, MSN, FNP-BC

    Christine brings her more than 15 years of clinical and leadership experience as a Nurse Practitioner to the practice of addiction medicine. She is passionate about individualized patient care as well as community education to end the stigma of substance use and mental health issues.

    Together with her physician partner, she started the first Emergency Room based withdrawal management service in the greater Phoenix area. Additionally, she maintains a private addiction medicine practice in Scottsdale, Arizona. Christine received her Master’s Degree in Nursing from Vanderbilt University where she was the 1998 Julia Hereford Merit Scholar. She resides in Phoenix, Arizona with her 2 sometimes well-behaved dogs. She enjoys live music, sports, and trying new hot sauces.

    Jennifer Harrison,

    PhD, LMSW, CAADC

    Jennifer r is a social worker, chemical addictions counselor, and an associate professor and the interim director for the School of Social Work at Western Michigan University.  Jennifer’s clinical work focuses on integrated substance use, mental health, and physical health services for individuals with co-occurring needs.  Her research interests and publication record include international social justice, co-occurring mental health, substance abuse, and medical needs among adults, implementation of evidence-based practices, and peer services in behavioral health.  

    Jennifer co-authored the book Tips and topics:  Opening the toolbox for transforming services and systems with David Mee-Lee.  She has presented on interprofessional research and teaching in the U.S and internationally, and served on multiple expert panels with SAMHSA.  Jennifer is a co-principal investigator in two HRSA funded projects to impact the interprofessional behavioral health workforce.  She has co-developed a digital application, Goal Scaling Solutions, for use in telehealth and education settings, to help people develop, monitor, and communicate about their goals for wellness and recovery.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Academy of Family Physicians (AAFP)

    The AAFP has reviewed The ASAM Criteria Course, and deemed it acceptable for 8.00 In-Person, Live (could include online) AAFP Prescribed Credit(s). Term of approval is from 01/29/2021 to 01/29/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    AMA/AAFP Equivalency

    AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

    ASWB Accreditation Statement

    The ASAM Criteria Course, Course #3225, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by The American Society of Addiction Medicine as an individual course. Individual courses, not providers, are approved at the course level. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ACE course approval period: 10/01/2020 - 10/01/2022. Social workers completing this course receive 8 Clinical continuing education credits.

    National Board for Certified Counselors ACEP

    The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Catherine Friedman, MD, FAPA, DFASAM – No Relevant Financial Disclosures 

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Christine R. Mulford, RN, MSN, FNP-BC – No Relevant Financial Disclosures 
    Phoenix ER and Medical Hospital/SHMDPC, Phoenix, AZ

    Jennifer Harrison, PhD, LMSW, CAADC – No Relevant Financial Disclosures 
    School of Social Work, Western Michigan University, Hopkins, MI


    Planning Committee Disclosure Information

    Corey Waller, MD, MS, DFASAM, FACEP, Chair (Chair) – No Relevant Financial Disclosures 

    David Mee-Lee, MD, FASAM – No Relevant Financial Disclosures 

    David R. Gastfriend, MD, DFASAM – No Relevant Financial Disclosures 

    Lewis Breitner, PhD, LADC, LMFT – No Relevant Financial Disclosures 

    Amy Davis, DO, MS, FACP, FAAHPM – No Relevant Financial Disclosures 

    Jennifer Harrison, PhD, LMSW, CAADC – No Relevant Financial Disclosures 

    Melissa Holland, MA, MD, FACOG, CAADC – No Relevant Financial Disclosures 

    Christine Mulford, RN, MSN, FNP-BC – No Relevant Financial Disclosures 

    Surita Rao, MBBS, FASAM – Does Disclose

    • John Snow, Inc., Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    J. Paul Seale, MD, FASAM – No Relevant Financial Disclosures 

    Gerald D. Shulman, MA, MAC, FACATA – No Relevant Financial Disclosures 

    How to Claim Credits


    To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

    STEP 1

    Complete the course.

    STEP 2

    Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

    STEP 3

    Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

    Fees


    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Resident, Student, Associate Members: $99.00

    All refund requests and cancellations must be made in writing and emailed to ASAM's Education Department: education@asam.org

    If you require ADA Accommodations, please contact ASAM's Education Department.

    All questions and concerns must be made in writing and emailed to ASAM's Education Department: education@asam.org

    System Requirements


    Please ensure that the location of where you plan to access the live stream program meets hardware, software and bandwidth requirements well in advance. 

    It is recommended that you use a PC or MAC with an updated Internet Browser. Internet Explorer is NOT recommended
    • Ensure that pop-ups blockers are disabled in your Internet browser settings.
    • Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers so you can hear the presenters.

    Browser Tests: Please take the following browser test. Please review the following Technical Requirements and be sure your system and networks are up-to-date. 

    https://support.zoom.us/hc/en-us/articles/115002262083-Joining-a-test-meeting

    Minimum System Requirements: 2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended)

    Minimum Browser Requirements: Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/ 

    • Windows 7 or later 
    • Mac OS X 10.9 or later 
    • Chrome 60 or greater 
    • Firefox 52 or greater 
    • Edge 14 or greater 
    • Safari 10 or greater 
    • iOS 10 or greater 

    Internet Explorer is NOT recommended 

    IP Addresses and Ports to Allow for HTML5: 

    • 72.32.161.112 port 80, 443 (web and audio) 
    • 72.32.200.104 port 80, 443 (web and audio) 
    • 72.32.221.65 ports 80, 443 (web and audio)
    • 72.32.221.66 ports 80, 443 (web and audio)
    • 67.203.7.114 ports 80, 443 (web and audio)
    • Register
      • Non-Member - $199
      • Regular Member - $149
      • Retired - $149
      • Early Career Physician - $149
      • Resident - $99
      • Student - $99
      • Associate - $99
      • ASAM Staff - Free!
      • International Member - $149
      • Emeritus Member - $149
      • Provisional Member - $149
      • Fellow Member - $149
      • Honorary Member - $149
      • CRT Member - $149
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - MOC - Thursday, February 18, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 02/18/2021 at 8:00 AM (EST)

    The ASAM Treatment of Opioid Use Disorder Course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices.

    image

    Host: Michigan Opioid Collaborative

    Thursday, February 18, 2021| 8:00 am - 5:00 pm ET 

    Location: Ann Arbor, MI

    Live Virtual Course

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD - Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board 

    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information




    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    • Fill out the Waiver Notification Form on SAMHSA’s website. You can upload your CME certificate directly the waiver notification form.


    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Tampa, FL - Saturday, February 13, 2021

    Product not yet rated Contains 7 Component(s), Includes Credits Includes a Live Web Event on 02/13/2021 at 8:00 AM (EST)

    The ASAM Treatment of Opioid Use Disorder Course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: Florida Perinatal Quality Collaborative

    Date: Saturday, February 13, 2021 | 8:00 am - 12:30 pm ET

    Live Virtual Course

    Online Portion Due: Friday, February 12, 2021

    This course is offered in partnership with the American College of Obstetricians and Gynecologists (ACOG). The curriculum for this course has been specifically designed for women's health providers.

    Overview

    Welcome to The ASAM Treatment of Opioid Use Disorder Course online access. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live in person or via live webinar learning. The live in person or via live webinar portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live in person or via live webinar portion. You must complete both portions to receive credit for the course. 

    Getting Started

    To begin the online portion of the course, please log-in to your left and locate the box that says "View Course." If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password.  If you have any questions, please contact education@ASAM.org.

    Learning Objectives

    1. Identify the importance of screening for substance use disorders
    2. Describe the mechanism of opioid withdrawal
    3. Discuss options to treat opioid withdrawal
    4. Explain the safety and efficacy of buprenorphine to treat opioid use disorder
    5. Explain the safety of medications in antepartum, postpartum, and breastfeeding period
    6. Describe how to start a patient (induction) on buprenorphine in an office-based setting
    7. Discuss successful non-pharmacological ways to treat Neonatal Abstinence Syndrome

    Overall Objective

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD – Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board
    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information



    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - $25
      • Regular Member - $25
      • Retired - $25
      • Early Career Physician - $25
      • Resident - $25
      • Student - $25
      • Associate - $25
      • ASAM Staff - Free!
      • International Member - $25
      • Emeritus Member - $25
      • Provisional Member - $25
      • Fellow Member - $25
      • Honorary Member - $25
      • CRT Member - $25
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Somerville, NJ - Saturday, February 6, 2021

    Product not yet rated Contains 7 Component(s), Includes Credits Includes a Live Web Event on 02/06/2021 at 8:00 AM (EST)

    The ASAM Treatment of Opioid Use Disorder Course: Includes Waiver Qualifying Requirements covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: New Jersey Perinatal Quality Collaborative

    Date: Saturday, February 6, 2021 | 8:00 am - 12:30 pm ET

    Live Virtual Course

     

    Online Portion Due: Friday, February 5, 2021

    This course is offered in partnership with the American College of Obstetricians and Gynecologists (ACOG). The curriculum for this course has been specifically designed for women's health providers.

    Overview

    Welcome to The ASAM Treatment of Opioid Use Disorder Course online access. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live in person or via live webinar learning. The live in person or via live webinar portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live in person or via live webinar portion. You must complete both portions to receive credit for the course. 

    Getting Started

    To begin the online portion of the course, please log-in to your left and locate the box that says "View Course." If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password.  If you have any questions, please contact education@ASAM.org.

    Learning Objectives

    1. Identify the importance of screening for substance use disorders
    2. Describe the mechanism of opioid withdrawal
    3. Discuss options to treat opioid withdrawal
    4. Explain the safety and efficacy of buprenorphine to treat opioid use disorder
    5. Explain the safety of medications in antepartum, postpartum, and breastfeeding period
    6. Describe how to start a patient (induction) on buprenorphine in an office-based setting
    7. Discuss successful non-pharmacological ways to treat Neonatal Abstinence Syndrome

    Overall Objective

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    California Consortium of Addiction Programs and Professionals (CCAPP)

    This educational program is approved by CCAPP: #OS-20-330-1222

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Surgery (ABS)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Benjamin Bearnot, MD – Does Disclose

    • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board
    • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Planning Committee


    Faculty Disclosure Information

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures 
    Mount Sinai Beth Israel, New York, NY

    Marian Currens, CRNP – Does Disclose 
    University of Maryland Baltimore, Baltimore, MD

    • ASAM, Consultant/Advisory Board, Clinical Condition: MedNP ED

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures 
    First Judicial District Court, Santa Fe, NM

    Daniel P. Alford, MD, MPH, DFASAM - No Relevant Financial Disclosures 
    Boston Medical School and Boston University School, Boston, MA

    Corey Waller, MD, MS, DFASAM, FACEP – No Relevant Financial Disclosures 
    Health Management Associates, Lansing, MI


    Planning Committee Disclosure Information

    Melissa Weimer, DO, MCR, FASAM – Does Disclose

    • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

    Deanna Wilson, MD, MPH– No Relevant Financial Disclosures
    Pittsburgh, PA

    Alta DeRoo, MD, FASAM – Does Disclose

    • Indivior, Speaker honorarium
    • Alkermes, Speaker honorarium

    Soraya Azari, MD – No Relevant Financial Disclosures
    San Francisco, CA

    Kristen Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
    Atlanta, GA

    Matt Tierney, NP, CNS – No Relevant Financial Disclosures
    San Francisco, CA

    Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
    Santa Fe, NM

    Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
    New York, NY

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - $25
      • Regular Member - $25
      • Retired - $25
      • Early Career Physician - $25
      • Resident - $25
      • Student - $25
      • Associate - $25
      • ASAM Staff - Free!
      • International Member - $25
      • Emeritus Member - $25
      • Provisional Member - $25
      • Fellow Member - $25
      • Honorary Member - $25
      • CRT Member - $25
    • More Information